• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $QSI

    Quantum-Si Incorporated

    Subscribe to $QSI
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si incorporated operates first next-generation protein sequencing and genomics platform for healthcare industries. It offers a single molecule detection solution to decode the molecules of life, including sample preparation, single molecule, massively parallel, and protein identification. The company's technology has the applications in proteomics, single cell, transcriptomics, genomics, metabolomics, and drug testing and screening fields. The company is based in Guilford, Connecticut. Quantum-Si incorporated is a subsidiary of 4Catalyzer Corporation.

    IPO Year: 2020

    Exchange: NASDAQ

    Website: quantum-si.com

    Peers

    $QUBT

    Recent Analyst Ratings for Quantum-Si Incorporated

    DatePrice TargetRatingAnalyst
    2/7/2025$3.75Buy
    Alliance Global Partners
    12/8/2023$3.00Buy
    H.C. Wainwright
    9/25/2023$3.50 → $2.00Buy → Hold
    Canaccord Genuity
    10/20/2021$13.00Buy
    Canaccord Genuity
    See more ratings

    Quantum-Si Incorporated Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Quantum-Si Incorporated

      SC 13D/A - Quantum-Si Inc (0001816431) (Subject)

      9/17/24 4:24:56 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Quantum-Si Incorporated

      SC 13G/A - Quantum-Si Inc (0001816431) (Subject)

      6/28/24 5:16:32 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G filed by Quantum-Si Incorporated

      SC 13G - Quantum-Si Inc (0001816431) (Subject)

      2/13/24 9:41:18 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G filed by Quantum-Si Incorporated

      SC 13G - Quantum-Si Inc (0001816431) (Subject)

      2/5/24 6:08:57 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G/A filed by Quantum-Si Incorporated (Amendment)

      SC 13G/A - Quantum-Si Inc (0001816431) (Subject)

      1/29/24 5:25:49 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G/A filed by Quantum-Si Incorporated (Amendment)

      SC 13G/A - Quantum-Si Inc (0001816431) (Subject)

      1/29/24 4:00:59 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13D/A filed by Quantum-Si Incorporated (Amendment)

      SC 13D/A - Quantum-Si Inc (0001816431) (Subject)

      9/13/23 4:44:55 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G/A filed by Quantum-Si Incorporated (Amendment)

      SC 13G/A - Quantum-Si Inc (0001816431) (Subject)

      7/10/23 11:26:38 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G/A filed by Quantum-Si Incorporated (Amendment)

      SC 13G/A - Quantum-Si Inc (0001816431) (Subject)

      2/10/23 1:54:29 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • SEC Form SC 13G filed by Quantum-Si Incorporated

      SC 13G - Quantum-Si Inc (0001816431) (Subject)

      2/3/23 12:10:01 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials

    Quantum-Si Incorporated Press Releases

    Fastest customizable press release news feed in the world

    See more

    Quantum-Si Incorporated Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Quantum-Si to Report First Quarter 2025 Financial Results on May 15, 2025

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced that it will report financial results for the first quarter 2025 on Thursday, May 15, 2025. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, individuals can register here to receive a dial-in number and personali

      4/24/25 8:00:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Begins Shipping Platinum® Pro, Advancing Accessibility in Next-Gen Protein Sequencing™

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, announces the start of shipments for its latest benchtop sequencer, Platinum® Pro. This groundbreaking instrument offers protein analysis with single-molecule precision, aiming to make Next-Gen Protein Sequencing™ more accessible to laboratories worldwide. Platinum Pro delivers a comprehensive solution for sequencing and analyzing proteins through a simple, integrated workflow. Building upon the foundation of innovation established by the original Platinum, the new system introduces advanced features tailored to the evolving needs of researchers and biopharmaceutical customers. Key

      3/26/25 8:00:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si to Participate in DNAnexus Webinar on Large Scale Proteomics in Multi-Omics Research

      Validate multi-omics findings at the single-molecule level with Next-Gen Protein Sequencing™ Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, announces participation in an upcoming DNAnexus webinar focused on the role of proteomics in multi-omics research. This discussion will explore how the integration of proteomics data with other omics datasets is driving new discoveries in disease research, including cancer. When: March 25, 2025, at 8 a.m. PT/11 a.m. ET Attendees will learn about: The growing impact of proteomics in multi-omics analysis Applications for cancer and other disease research Technologies and strategies fo

      3/20/25 8:00:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced that the Compensation Committee of Quantum-Si's Board of Directors has granted 20,833 restricted stock units ("RSUs") to new employees under the Company's previously adopted Quantum-Si Incorporated 2023 Inducement Equity Incentive Plan, as amended (the "2023 Inducement Plan"). The RSUs were granted as an inducement material to the new employees becoming an employee of Quantum-Si in accordance with Nasdaq Listing Rule 5635(c)(4). The 2023 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Quantum-Si

      3/13/25 4:05:00 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results

      Achieves First Quarterly Revenue Over $1 Million Completes Capital Raises of $86 Million Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced financial results for the fourth quarter and full year ended December 31, 2024. Press Release Highlights Reported revenue of $1.2 million for the fourth quarter of 2024 and $3.1 million for the full year 2024 (representing a 183% full year-over-year growth) Raised capital of over $86 million between the fourth quarter of 2024 and first week of 2025 (extending cash runway into the second half of 2027) Announced the launch of Platinum® Pro in January 2025, with shipp

      3/3/25 4:05:00 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si's Customers and Researchers to Showcase Next-Generation Protein Sequencing™ at AGBT 2025

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, and several distinguished researchers will be presenting new research and applications at the 2025 Advances in Genome Biology and Technology (AGBT) General Meeting February 23-26th. Quantum-Si, the pioneer in Next-Generation Protein Sequencing (NGPS™) will feature groundbreaking research through one company-led poster and two customer-led posters highlighting the transformative capabilities of NGPS in multi-omics research and drug discovery. Scientific Posters Highlighting NGPS Innovation Beyond the genome: Advancing our understanding of the proteome with Next-Generation Protein

      2/18/25 4:05:00 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si and Researchers to Showcase Next-Generation Protein Sequencing™ at US HUPO 2025

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, and several distinguished researchers will highlight advances in Next-Generation Protein Sequencing™ (NGPS™) at the US Human Proteome Organization's 2025 conference in Philadelphia, Pennsylvania through a panel discussion and multiple poster presentations. Sponsored Panel Discussion: Breaking Boundaries in Proteomics Quantum-Si is sponsoring and moderating the panel event "Breaking Boundaries: How Next-Generation Protein Sequencing™ is Shaping the Future of Proteomics" on February 25 from 12:30-1:30 PM ET. The session will provide an overview of the latest research leveraging Qu

      2/13/25 8:00:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced that it will report financial results for the fourth quarter and full year 2024 on Monday, March 3, 2025. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, individuals can register here to receive a dial-in numbe

      2/12/25 8:00:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Preprint from Northwestern University Highlights Complementary Proteomic Analysis of Interleukin-6 Using Next-Generation Protein Sequencing™ and Mass Spectrometry

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, announces a newly released preprint from researchers at Northwestern University, titled "Next-Generation Protein Sequencing and individual ion mass spectrometry enable complementary analysis of interleukin-6." The publication demonstrates the power of combining two cutting-edge technologies, Quantum-Si's Next-Generation Protein Sequencing™ (NGPS™) on Platinum®, and Individual Ion Mass Spectrometry (I2MS), to achieve a detailed analysis of key regions of the cytokine interleukin-6 (IL-6). IL-6 is a key immune regulator and therapeutic target; however, its proteoform diversity can p

      2/11/25 8:00:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Establishes Scientific Advisory Board to Shape Next-Generation Proteomic Technologies

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, announces the formation of its Scientific Advisory Board. Comprised of distinguished experts in proteomics, genomics, bioinformatics, chemistry, and engineering, the board will play a critical role in shaping Quantum-Si's scientific and development strategy, identifying emerging trends and applications, and strengthening engagement within the scientific community. Dr. Gloria M. Sheynkman, a leading expert in proteoform characterization and single-molecule protein sequencing, has been named Chair of the Scientific Advisory Board. Dr. Sheynkman is an Assistant Professor at the Unive

      2/4/25 8:00:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • President & CEO Hawkins Jeffrey Alan sold $32,846 worth of shares (23,707 units at $1.39), decreasing direct ownership by 0.89% to 2,646,716 units (SEC Form 4)

      4 - Quantum-Si Inc (0001816431) (Issuer)

      3/24/25 6:48:37 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • General Counsel & Corp. Secr. Lapointe Christian sold $6,783 worth of shares (4,896 units at $1.39), decreasing direct ownership by 0.50% to 983,480 units (SEC Form 4)

      4 - Quantum-Si Inc (0001816431) (Issuer)

      3/24/25 6:42:56 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Chief Financial Officer Keyes Jeffry R. sold $11,951 worth of shares (8,626 units at $1.39), decreasing direct ownership by 0.72% to 1,188,194 units (SEC Form 4)

      4 - Quantum-Si Inc (0001816431) (Issuer)

      3/24/25 6:34:27 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Chief Product Officer Vieceli John S. sold $5,981 worth of shares (4,317 units at $1.39), decreasing direct ownership by 0.50% to 864,509 units (SEC Form 4)

      4 - Quantum-Si Inc (0001816431) (Issuer)

      3/24/25 6:11:36 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Chief Product Officer Vieceli John S. was granted 708,333 shares, increasing direct ownership by 441% to 868,826 units (SEC Form 4)

      4 - Quantum-Si Inc (0001816431) (Issuer)

      3/14/25 5:06:08 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • President & CEO Hawkins Jeffrey Alan was granted 1,666,666 shares, increasing direct ownership by 166% to 2,670,423 units (SEC Form 4)

      4 - Quantum-Si Inc (0001816431) (Issuer)

      3/14/25 5:06:07 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Chief Commercial Officer Bennett Todd C. was granted 208,333 shares, increasing direct ownership by 41% to 718,485 units (SEC Form 4)

      4 - Quantum-Si Inc (0001816431) (Issuer)

      3/14/25 5:06:09 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Chief Financial Officer Keyes Jeffry R. was granted 750,000 shares, increasing direct ownership by 168% to 1,196,820 units (SEC Form 4)

      4 - Quantum-Si Inc (0001816431) (Issuer)

      3/14/25 5:06:10 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • General Counsel & Corp. Secr. Lapointe Christian was granted 416,666 shares, increasing direct ownership by 73% to 988,376 units (SEC Form 4)

      4 - Quantum-Si Inc (0001816431) (Issuer)

      3/14/25 5:06:11 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Director Rothberg Jonathan M sold $11,716,735 worth of shares (3,506,267 units at $3.34) (SEC Form 4)

      4 - Quantum-Si Inc (0001816431) (Issuer)

      12/31/24 8:27:55 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials

    Quantum-Si Incorporated Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Alliance Global Partners initiated coverage on Quantum-Si with a new price target

      Alliance Global Partners initiated coverage of Quantum-Si with a rating of Buy and set a new price target of $3.75

      2/7/25 8:29:38 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • H.C. Wainwright initiated coverage on Quantum-Si with a new price target

      H.C. Wainwright initiated coverage of Quantum-Si with a rating of Buy and set a new price target of $3.00

      12/8/23 7:55:31 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si downgraded by Canaccord Genuity with a new price target

      Canaccord Genuity downgraded Quantum-Si from Buy to Hold and set a new price target of $2.00 from $3.50 previously

      9/25/23 9:04:14 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Canaccord Genuity initiated coverage on Quantum-Si with a new price target

      Canaccord Genuity initiated coverage of Quantum-Si with a rating of Buy and set a new price target of $13.00

      10/20/21 8:21:01 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials

    Quantum-Si Incorporated SEC Filings

    See more

    Quantum-Si Incorporated Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Quantum-Si Incorporated filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Quantum-Si Inc (0001816431) (Filer)

      4/10/25 4:49:41 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • SEC Form DEFA14A filed by Quantum-Si Incorporated

      DEFA14A - Quantum-Si Inc (0001816431) (Filer)

      3/20/25 4:12:20 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • SEC Form DEF 14A filed by Quantum-Si Incorporated

      DEF 14A - Quantum-Si Inc (0001816431) (Filer)

      3/20/25 4:07:34 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • SEC Form S-8 filed by Quantum-Si Incorporated

      S-8 - Quantum-Si Inc (0001816431) (Filer)

      3/3/25 4:51:03 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • SEC Form 10-K filed by Quantum-Si Incorporated

      10-K - Quantum-Si Inc (0001816431) (Filer)

      3/3/25 4:19:48 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Quantum-Si Inc (0001816431) (Filer)

      3/3/25 4:08:58 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SCHEDULE 13G/A filed by Quantum-Si Incorporated

      SCHEDULE 13G/A - Quantum-Si Inc (0001816431) (Subject)

      2/14/25 11:23:34 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SCHEDULE 13G/A filed by Quantum-Si Incorporated

      SCHEDULE 13G/A - Quantum-Si Inc (0001816431) (Subject)

      2/13/25 3:35:22 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SCHEDULE 13G/A filed by Quantum-Si Incorporated

      SCHEDULE 13G/A - Quantum-Si Inc (0001816431) (Subject)

      2/4/25 6:19:56 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SCHEDULE 13G/A filed by Quantum-Si Incorporated

      SCHEDULE 13G/A - Quantum-Si Inc (0001816431) (Subject)

      1/10/25 9:21:25 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Chief Financial Officer Keyes Jeffry R. bought $43,465 worth of shares (50,000 units at $0.87), increasing direct ownership by 13% to 446,820 units (SEC Form 4)

      4 - Quantum-Si Inc (0001816431) (Issuer)

      8/13/24 6:01:25 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • President & CEO Hawkins Jeffrey Alan bought $21,272 worth of shares (25,000 units at $0.85), increasing direct ownership by 3% to 1,003,757 units (SEC Form 4)

      4 - Quantum-Si Inc (0001816431) (Issuer)

      8/13/24 6:01:28 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Director Kummeth Charles R. bought $148,459 worth of shares (170,000 units at $0.87), increasing direct ownership by 92% to 355,000 units (SEC Form 4)

      4 - Quantum-Si Inc (0001816431) (Issuer)

      8/13/24 6:01:24 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • General Counsel & Corp. Secr. Lapointe Christian bought $21,610 worth of shares (25,000 units at $0.86), increasing direct ownership by 5% to 571,710 units (SEC Form 4)

      4 - Quantum-Si Inc (0001816431) (Issuer)

      8/13/24 6:01:26 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Hawkins Jeffrey Alan was granted 953,757 shares and bought $44,000 worth of shares (25,000 units at $1.76) (SEC Form 4)

      4 - Quantum-Si Inc (0001816431) (Issuer)

      3/18/24 8:21:04 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Lapointe Christian bought $17,400 worth of shares (10,000 units at $1.74) and was granted 289,017 shares, increasing direct ownership by 121% to 546,710 units (SEC Form 4)

      4 - Quantum-Si Inc (0001816431) (Issuer)

      3/18/24 8:07:24 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Keyes Jeffry R. bought $80,500 worth of shares (50,000 units at $1.61) (SEC Form 4)

      4 - Quantum-Si Inc (0001816431) (Issuer)

      3/6/24 5:09:05 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials

    Quantum-Si Incorporated Leadership Updates

    Live Leadership Updates

    See more
    • Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced the appointment of Charles ("Chuck") Kummeth to the role of independent Chairman of the Board, effective May 27, 2024. Mr. Kummeth has over 35 years of leadership experience in Life Sciences most recently as President and CEO of Bio-Techne. During Mr. Kummeth's tenure at Bio-Techne, he oversaw tremendous growth across all aspects of the business including annual revenue growth from $300M to over $1.1B, growth in the employee base from 800 to over 3,000, and the successful execution of 19 acquisitions, all while maintaining a 35% or better EBITDA level. Under Mr. Ku

      5/30/24 4:05:00 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Appoints Former Illumina and Cisco Systems Executive, Paula Dowdy, to its Board of Directors

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced the appointment of Paula Dowdy, a senior executive with more than 35 years of experience across life sciences, enterprise software, and technology industries, to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240321183506/en/Paula Dowdy (Photo: Business Wire) Ms. Dowdy currently serves on the Board of Directors for SPT Labtech, a world leading lab automation tools company based in the UK and is an advisor at EQT Life Sciences, one of Europe's leading investors targeting innovative

      3/21/24 4:05:00 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Introduces World's First Next-Generation Protein Sequencer™ in Japan with Addition of New Distributor

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced that it has entered into an agreement with a new distributor who will make the company's protein sequencing instrument, Platinum® available for the first time in Japan. TOMY Digital Biology Co., Ltd., a renowned importer and distributor with a rich history dating back to the 1950s, will distribute Quantum-Si's next-generation protein sequencer™ and associated consumables throughout Japan. "Working with Quantum-Si marks a pivotal moment for TOMY Digital Biology, aligning with our commitment to advancing life sciences. We're poised to empower Japanese researchers wit

      1/18/24 8:30:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Expands Global Reach with Addition of New Distributor

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced that it has entered into an agreement with a new international distributor as demand grows for its first-to-market next-generation protein sequencing™ instrument, Platinum™. 3Genes Distribution a.s., a prominent technology provider specializing in life science and diagnostics in Eastern Europe will distribute Quantum-Si's Platinum across the Czech Republic, Slovakia, and Hungary. Dominik Véle, a board member of 3Genes said, "Through our agreement with Quantum-Si, 3Genes aims to pioneer proteomic innovation in our Eastern European markets, forging a new era in life

      12/12/23 8:30:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Adds Distributor ELTA 90 as Demand for Platinum™ Grows

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced that it had entered into an agreement with Elta 90 to distribute Quantum-Si's groundbreaking Platinum™ instrument and consumables in Southeast Europe as demand grows for the first of its kind next-generation protein sequencing™ platform. This agreement between Quantum-Si and ELTA 90 holds immense promise for accelerating scientific research by delivering the game changing tool, Platinum, which interrogates proteins with single-molecule amino acid resolution. "We are thrilled to partner with ELTA 90 in this venture. The synergy between Quantum-Si and ELTA 90 repre

      11/15/23 8:30:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Honored as Proteomics Company of the Year by the BioTech Breakthrough Awards

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced it has received the "Proteomics Company of the Year" award from the BioTech Breakthrough Awards as part of the program's 2023 award recipients for its first of a kind protein sequencing instrument. "Since the groundbreaking introduction of Platinum™, Quantum-Si has swiftly emerged as an industry trailblazer, galvanizing the scientific community with a pioneering focus on proteomics," said Quantum-Si Chief Executive Officer Jeff Hawkins. "Receiving the coveted Proteomics Company of the Year award in 2023 is a testament to the extraordinary caliber of our team and th

      11/8/23 8:15:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Presents its Vision to Transform Genomics and Proteomics Research at ASHG 2023

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced it will showcase next-generation benchtop protein sequencing instrument, Platinum™, and the Company's vision to transform genomics and proteomics research, at the American Society of Human Genetics (ASHG) conference, in Washington, D.C., November 1-5. "Platinum, stands as a groundbreaking advancement in next-generation protein sequencing™ moving the field beyond the limitations posed by mass spectrometry and immunoassays. This robust tool is a solution, enabling precise, single-molecule resolution," remarked Quantum-Si Chief Executive Officer Jeff Hawkins. He conti

      10/31/23 8:00:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Appoints Biotech Executive and Entrepreneur, Amir Jafri, to its Board of Directors

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced the appointment of Amir Jafri, President and CEO of Immunicom, Inc., to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230921747791/en/(Photo: Business Wire) "Amir's leadership track record speaks for itself," said Jeff Hawkins, CEO of Quantum-Si. "He has successfully managed businesses across multiple industries and has built and led world class R&D organizations responsible for advanced technology development and the launch of over 50 products and technologies globally. His exper

      9/21/23 8:00:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Announces the Appointment of Industry Veteran Johan Denecke as Senior Vice President of Operations

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced the appointment of Johan Denecke as Senior Vice President of Operations, effective June 20, 2023. Mr. Denecke will be responsible for scaling up production and driving operational and quality excellence in support of the commercialization of Quantum-Si's next-generation, single-molecule protein sequencing platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230621345723/en/(Photo: Business Wire) Mr. Denecke brings more than 20 years of experience as a cross-functional operations executive in engineeri

      6/21/23 8:00:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Debuts New Headquarters in Branford, Connecticut

      World-class laboratory and office space underpins the scaling of Quantum-Si's operational and development capabilities in support of its goal to revolutionize protein sequencing. Company continues rich 10 year history in Connecticut with new facility through 2029 Quantum-Si- Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced the official debut of The Company's new state-of-the-art, 29,420 square-foot headquarters in Branford, Connecticut. The new facility extends The Company's decade long history in Connecticut, and includes a 7-year lease which will keep Quantum-Si in Branford at least through 2029. The official ribbon cut

      6/7/23 8:00:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials

    Quantum-Si Incorporated Financials

    Live finance-specific insights

    See more
    • Quantum-Si to Report First Quarter 2025 Financial Results on May 15, 2025

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced that it will report financial results for the first quarter 2025 on Thursday, May 15, 2025. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, individuals can register here to receive a dial-in number and personali

      4/24/25 8:00:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results

      Achieves First Quarterly Revenue Over $1 Million Completes Capital Raises of $86 Million Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced financial results for the fourth quarter and full year ended December 31, 2024. Press Release Highlights Reported revenue of $1.2 million for the fourth quarter of 2024 and $3.1 million for the full year 2024 (representing a 183% full year-over-year growth) Raised capital of over $86 million between the fourth quarter of 2024 and first week of 2025 (extending cash runway into the second half of 2027) Announced the launch of Platinum® Pro in January 2025, with shipp

      3/3/25 4:05:00 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced that it will report financial results for the fourth quarter and full year 2024 on Monday, March 3, 2025. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, individuals can register here to receive a dial-in numbe

      2/12/25 8:00:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Reports Third Quarter 2024 Financial Results

      Sales Pipeline is Accelerating and New Kits Remain on Track for Q4 Launch Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced financial results for the third quarter ended September 30, 2024. Press Release Highlights Reported revenue of $787,000 for the third quarter of 2024 Announced that Liberate Bio has integrated Platinum® Next-Generation Sequencing into their platform for developing novel gene therapies with improved targeting capabilities Announced appointments of industry veteran Todd Bennett as Chief Commercial Officer ("CCO"), John Vieceli, Ph.D. as Chief Product Officer and Lindsay Thompson as C

      11/12/24 7:30:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced that it will report financial results for the third quarter of 2024 on Tuesday, November 12, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 8:00 AM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, individuals can register here to receive a dial-in number and personalized PIN to participate in the call. An archived webcast of the event

      10/23/24 6:00:00 AM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Reports Second Quarter 2024 Financial Results

      Announces Release of Version 3 Sequencing Kit Announces Two Additional Kit Launches Expected by End of 2024 Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced financial results for the second quarter ended June 30, 2024.   Press Release Highlights   Reported revenue of $622,000 in the second quarter of 2024 Completed the first quarter of full commercial launch of the Platinum® instrument in Q2 2024 Announces the launch of the version 3 sequencing kit Announced appointment of Chuck Kummeth as independent Chairman of the Board of Directors Expect to l

      8/7/24 4:02:00 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si to Report Second Quarter 2024 Financial Results on August 7, 2024

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced that it will report financial results for the second quarter of 2024 on Wednesday, August 7, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, individuals can register here to receive a dial-in number and personalized PIN to participate in the call. An archived webcast of the eve

      7/17/24 4:05:00 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Reports First Quarter 2024 Financial Results

      Executed Full Commercial Launch of Platinum® Instrument Reaffirms Full Year 2024 Financial Guidance Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced financial results for the first quarter ended March 31, 2024. Press Release Highlights Reported revenue of $457,000 in the first quarter of 2024 Commenced its full commercial launch of its Platinum® instrument at the end of March 2024 On track to launch version 3 of its sequencing kit, which is expected by the end of Q3 2024 Announced addition of Paula Dowdy to the Board of Directors Announced the release of a new version of Platinum® Analysis Soft

      5/9/24 4:01:00 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024

      Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced that it will report financial results for the first quarter 2024 on Thursday, May 9, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, individuals can register here to receive a dial-in number and personalized PIN to participate in the call. An archived webcast of the event will b

      4/18/24 4:05:00 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials
    • Quantum-Si Reports Fourth Quarter and Full Year 2023 Financial Results

      Finalizing Commercial Readiness for Expected Full Commercial Launch by the End of Q1 2024 Releases Full Year 2024 Financial Guidance Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced financial results for the fourth quarter and full year ended December 31, 2023. Press Release Highlights Recorded revenue of $400,000 in the fourth quarter of 2023 as the Company continued its previously communicated controlled commercial launch of its Platinum® instrument Finalizing commercial readiness for expected full commercial launch by the end of Q1 2024 Launched version 2 of its sequencing kit in early February 2

      2/29/24 4:05:00 PM ET
      $QSI
      Industrial Machinery/Components
      Industrials